102
Views
10
CrossRef citations to date
0
Altmetric
Nephrology

Relationship of insulin resistance in chronic haemodialysis patients with inflammatory indicators, malnutrition, echocardiographic parameters and 24 hour ambulatory blood pressure monitoring

, , , , &
Pages 257-264 | Received 03 Apr 2009, Accepted 28 Oct 2009, Published online: 09 Apr 2010

References

  • Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999;56:2214–9.
  • Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996;93:1809–71.
  • Schmitz O, Alberti KG, Christensen NJ, Hasling C, Hjøllund E, Beck-Nielsen H, Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique. Metabolism 1985;34:465–73.
  • Alvestrand A, Mujagic M, Wajngot A, Efendic S. Glucose intolerance in uremic patients. The relative contributions of impaired beta-cell function and insulin resistance. Clin Nephrol 1989;31:175–83.
  • Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Insulin resistance in essential hypertension. N Engl J Med 1987;317:350–7.
  • Kanauchi M, Kimura K, Akai Y, Saito Y. Insulin resistance and pancreatic beta-cell function in patients with hypertensive kidney disease. Nephrol Dial Transplant 2004;19:2025–9.
  • Kimmel PL, Peterson RA, Weihs KL, Shidler N, Simmens SJ, Alleyne S, Immunologic function and survival in haemodialysis patients. Kidney Int 1998;54:236–44.
  • Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998;32:107–14.
  • Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999;130:651–7.
  • Auwerx J, Bouillon R, Collen D, Geboers J. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 1988;8:68–72.
  • Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002;13:134–41.
  • Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC. A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant 1999;14:1732–8.
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment. Diabetologia 1985;28:c412–9.
  • Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Use of oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295–301.
  • Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T, Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol Dial Transplant 2008;23:1621–7.
  • Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD. Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 2004;43:1047–55.
  • Rasic-Milutinovic Z, Perunicić G, Pljesa S, Gluvić Z, Ilić M, Stokić E. The effect of nutritional status, body composition, inflammation and serum iron on the development of insulin resistance among patients on long-term hemodialysis. Med Pregl 2007;60(Suppl 2):33–8.
  • Zoccali C, Tripepi G, Cambareri F, Catalano F, Finocchiaro P, Cutrupi S, Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients. J Ren Nutr 2005;15:125–30.
  • Lee SW, Park GH, Lee SW, Song JH, Hong KC, Kim MJ. Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients. Nephrol Dial Transplant 2007;22:2554–62.
  • Kaftan HA, Evrengul H, Tanriverdi H, Kilic M. Effect of insulin resistance on left ventricular structural changes in hypertensive patients. Int Heart J 2006;47:391–400.
  • Dzurik R, Spustova V, Janekova K. The prevalence of insulin resistance in kidney disease patients before the development of renal failure. Nephron 1995;69:281–5.
  • Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998;53:1343–7.
  • Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003;14:469–77.
  • Shen DC, Shieh SM, Fuh MT, Wu DA, Chen YDI, Reaven GM. Resistance to insulin stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988;66:580–3.
  • Denker PS, Pollock VE. Fasting serum insulin levels in essential hypertension: a meta-analysis. Arch Intern Med 1992;152:1649–51.
  • Sarafidis PA, Bakris GL. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance? Am J Nephrol 2007;27:44–54.
  • Rowe JW, Young JB, Minaker KL, Stephens AL, Pallotta J, Landsberg L. Effects of insulin and glucose infusions on sympathetic nervous activity in normal man. Diabetes 1981;30:219–25.
  • Pfeile B, Dischaneit H. Effects of insulin on growth of cultured arterial smooth muscle cells. Diabetologia 1981;20:155–8.
  • De Fronzo RA. The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia 1981;21:161–71.
  • London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: followup of an interventional study. J Am Soc Nephrol 2001;12:2759–67.
  • Anan F, Takahashi N, OoIe T, Yufu K, Saikawa T, Yoshimatsu H. Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 2003;26:669–76.
  • Chen JW, Jen SL, Lee WL, Hsu NW, Lin SJ, Ting CT, Differential glucose tolerance in dipper and nondipper essential hypertension: the implications of circadian blood pressure regulation on glucose tolerance in hypertension. Diabetes Care 1998;21:1743–8.
  • Venkatesan J, Henrich WL. Anemia, hypertension, and myocardial dysfunction in end-stage renal disease. Am J Kidney Dis 1997;17:257–69.
  • Stenvinkel P. Inflammation in end-stage renal failure: could it be treated? Nephrol Dial Transplant 2002;17:33–8.
  • Vischer UM, Safar ME, Safar H, Iaria P, Le Dudal K, Henry O, Cardiometabolic determinants of mortality in a geriatric population: is there a “reverse metabolic syndrome”? Diabetes Metab 2009;35:108–14.
  • Kürşat S, Tekçe H, Ekmekçi C, Colak HB, Alici T. Relationship between the degree of malnutrition and echocardiographic parameters in hemodialysis patients. Nephron Clin Pract 2007;106:36–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.